Treatment of Hyperacidity in Pregnancy
Start with dietary and lifestyle modifications first, then escalate to calcium-containing antacids, followed by H2-receptor antagonists if needed, reserving proton pump inhibitors only for severe, refractory cases. 1
Stepwise Treatment Algorithm
First-Line: Dietary and Lifestyle Modifications
Begin by eliminating specific triggers 1:
- Avoid: spicy, fatty, acidic, and fried foods
- Eat: small, frequent, bland meals (BRAT diet: bananas, rice, applesauce, toast)
- Prioritize: high-protein, low-fat meals
- Identify and avoid specific food odors or activities that trigger symptoms
Second-Line: Non-Prescription Agents
If dietary changes fail, add 1, 2:
Calcium-containing antacids (preferred first choice)
- Safe and effective for immediate symptom relief
- Use as needed for breakthrough symptoms
Ginger: 250 mg capsule 4 times daily (ACOG-recommended) 1
Third-Line: Prescription Medications
- Preferred over PPIs during pregnancy
- All H2RAs are acceptable except nizatidine (avoid due to fetal teratogenicity in animal studies)
- Safe for use throughout pregnancy
Sucralfate: 1 g oral tablet, 3 times daily 2
- Particularly effective option
- Minimal systemic absorption
Fourth-Line: Proton Pump Inhibitors (Reserved for Severe Cases)
- Intractable symptoms unresponsive to H2RAs
- Complicated GERD
- Severe erosive esophagitis
Important PPI considerations:
- All PPIs are FDA Category B except omeprazole (Category C)
- Use lowest effective dose for shortest duration
- Discuss risks and benefits thoroughly with patient
Key Clinical Pearls
Pathophysiology to remember 1: Heartburn in pregnancy results from progesterone-induced relaxation of the lower esophageal sphincter, typically appearing in the latter part of pregnancy and resolving after delivery.
Common pitfall: The evidence provided focuses heavily on nausea/vomiting treatment, but these are distinct from heartburn. Don't confuse the two conditions—doxylamine and vitamin B6 are for nausea/vomiting, not heartburn 1.
Timing matters: Heartburn typically occurs in the second and third trimesters, unlike nausea/vomiting which peaks at 8-12 weeks 1.
Treatment Escalation Rationale
The stepwise approach prioritizes maternal and fetal safety 2, 3:
- Lifestyle modifications carry zero medication risk
- Antacids have no systemic absorption and extensive safety data
- H2RAs and sucralfate have favorable safety profiles with decades of pregnancy use
- PPIs are reserved for severe cases due to less extensive pregnancy data, though serious complications remain rare
Quality of evidence: The 2024 AGA guideline 1 provides the most current expert consensus, though it acknowledges that heartburn-specific pregnancy data remains limited compared to nausea/vomiting evidence. The research literature 2, 3 consistently supports this conservative, stepwise approach prioritizing non-pharmacologic interventions first.